Drug Inspector Suspended Over Negligence In Death Of Kalpana Mishra During Delivery; FIR Ordered Against Blood Centre In MP’s Rewa
Bhopal (Madhya Pradesh): The Madhya Pradesh Food and Drug Administration (FDA) has suspended Rewa district drug inspector Radheshyam Batti for alleged serious negligence, arbitrariness and indiscipline in connection with the death of Kalpana Mishra during delivery in Rewa. The suspension order was issued on Wednesday by FDA. Batti was the drug inspector responsible for the jurisdiction under…
The Madhya Pradesh Food and Drug Administration (FDA) has suspended Rewa district drug inspector Radheshyam Batti for alleged negligence and indiscipline related to the death of Kalpana Mishra during delivery in Rewa. The suspension order was issued on Wednesday by the FDA, following directions from the Public Health and Medical Education Department on September 15 and an ongoing inquiry by a committee constituted by the National Health Mission director on August 26.
Batti, who was responsible for the jurisdiction under which Atharva Blood Centre was operating, will be headquartered at the office of the deputy director, FDA, Shahdol, and will be entitled to subsistence allowance as per rules. Additionally, the FDA has directed the registration of a criminal case against Atharva Blood Centre over alleged irregularities, and its state licensing authority and controlling authority to coordinate with the drug inspector and ensure that the department is informed about the action taken.
Brief written by urgent.news from Free Press Journal's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
